The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis.

Konstantinos Prokopidis, Frank Moriarty, Gülistan Bahat, Joseph McLean, David D Church, Harnish P Patel

Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK. · pubmed

Paper

Abstract

Sarcopenia is associated with the loss of skeletal muscle function and mass. Nicotinamide precursors, such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), have received attention for their potential to improve NAD

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that nicotinamide mononucleotide and nicotinamide riboside can improve skeletal muscle mass and function. This research is relevant as it explores potential interventions that may address aspects of aging, specifically sarcopenia, which is a significant contributor to age-related decline in physical function.

Author of this paper? Send a correction.